| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schwartz Z et al. | Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. | 2009 | Ann Biomed Eng | pmid:19139991 |
| Olivares-Navarrete R et al. | Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. | 2014 | Ann Biomed Eng | pmid:25227453 |
| Schlieper G et al. | Analysis of calcifications in patients with coral reef aorta. | 2010 | Ann Vasc Surg | pmid:20144533 |
| Buckley KA and Fraser WD | Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses/potential therapeutic agents and biochemical markers. | 2002 | Ann. Clin. Biochem. | pmid:12564836 |
| Hofbauer LC | Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG). | 2006 | Ann. Endocrinol. (Paris) | pmid:16639364 |
| Quemerais-Durieu MA et al. | [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. | 2011 | Ann. Endocrinol. (Paris) | pmid:22008272 |
| Perifanis V et al. | Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia. | 2007 | Ann. Hematol. | pmid:17013645 |
| Christoforidis A et al. | Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia. | 2010 | Ann. Hematol. | pmid:20084381 |
| Korostishevsky M et al. | Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus. | 2008 Sep-Oct | Ann. Hum. Biol. | pmid:18821330 |
| Kwan JS et al. | Heritability of serum osteoprotegerin. | 2011 | Ann. Hum. Genet. | pmid:21762114 |
| Vistoropsky Y et al. | Osteoprotegerin plasma levels are strongly associated with polymorphisms in human homologue of the mouse progressive ankylosis (ANKH) gene. | 2007 | Ann. Hum. Genet. | pmid:17147692 |
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Dovio A et al. | [Pathophysiological significance and clinical utility of circulating osteoprotegerin]. | 2004 Jan-Mar | Ann. Ital. Med. Int. | pmid:15176704 |
| Schinke T et al. | Molecular determinants of arterial calcification. | 1998 | Ann. Med. | pmid:9920355 |
| MacNee W | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. | 2013 | Ann. Med. | pmid:23110517 |
| Montagnana M et al. | The role of osteoprotegerin in cardiovascular disease. | 2013 | Ann. Med. | pmid:23110639 |
| Weitzmann MN and Pacifici R | T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. | 2007 | Ann. N. Y. Acad. Sci. | pmid:18083938 |
| Wimalawansa SJ | Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. | 2007 | Ann. N. Y. Acad. Sci. | pmid:18056048 |
| Lin-Su K and New MI | Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia. | 2007 | Ann. N. Y. Acad. Sci. | pmid:18056052 |
| Leibbrandt A and Penninger JM | RANK/RANKL: regulators of immune responses and bone physiology. | 2008 | Ann. N. Y. Acad. Sci. | pmid:19076348 |
| Glass DA and Karsenty G | Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831912 |
| Whyte MP | Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831914 |
| Zallone A | Direct and indirect estrogen actions on osteoblasts and osteoclasts. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831916 |
| Liu XH et al. | Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831922 |
| Matsumoto T and Abe M | Bone destruction in multiple myeloma. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831932 |
| Brunetti G et al. | The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831934 |
| Boumans MJ et al. | Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. | 2012 | Ann. Rheum. Dis. | pmid:22072013 |
| Sagar DR et al. | Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. | 2014 | Ann. Rheum. Dis. | pmid:23723320 |
| Castellino G et al. | Is there any role for tumour necrosis factor related apoptosis inducing ligand-osteoprotegerin (TRAIL-OPG) interaction in rheumatoid arthritis? | 2008 | Ann. Rheum. Dis. | pmid:18621972 |
| Itonaga I et al. | Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. | 2000 | Ann. Rheum. Dis. | pmid:10627423 |
| Skoumal M et al. | Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis. | 2004 | Ann. Rheum. Dis. | pmid:14722219 |
| Gengenbacher M et al. | Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. | 2008 | Ann. Rheum. Dis. | pmid:17720725 |
| Ruocco MG and Karin M | IKK{beta} as a target for treatment of inflammation induced bone loss. | 2005 | Ann. Rheum. Dis. | pmid:16239395 |
| Smith MD et al. | Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. | 2003 | Ann. Rheum. Dis. | pmid:12634226 |
| Crotti TN et al. | Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. | 2002 | Ann. Rheum. Dis. | pmid:12429533 |
| Dai SM et al. | Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. | 2004 | Ann. Rheum. Dis. | pmid:15479886 |
| Wagner EF and Matsuo K | Signalling in osteoclasts and the role of Fos/AP1 proteins. | 2003 | Ann. Rheum. Dis. | pmid:14532157 |
| van Tuyl LH et al. | Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | 2010 | Ann. Rheum. Dis. | pmid:20525836 |
| Pathan E et al. | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. | 2013 | Ann. Rheum. Dis. | pmid:22984171 |
| Feige U | Osteoprotegerin. | 2001 | Ann. Rheum. Dis. | pmid:11890662 |
| O' Gradaigh D et al. | Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. | 2004 | Ann. Rheum. Dis. | pmid:15020327 |
| Jones DH et al. | Role of RANKL and RANK in bone loss and arthritis. | 2002 | Ann. Rheum. Dis. | pmid:12379618 |
| González-Alvaro I et al. | Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists. | 2007 | Ann. Rheum. Dis. | pmid:17666448 |
| Gravallese EM | Bone destruction in arthritis. | 2002 | Ann. Rheum. Dis. | pmid:12379632 |
| Vis M et al. | Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. | 2006 | Ann. Rheum. Dis. | pmid:16606653 |
| Bao BY et al. | Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer. | 2010 | Ann. Surg. Oncol. | pmid:20204532 |
| Kress DC | Invited commentary. | 2013 | Ann. Thorac. Surg. | pmid:23992687 |
| Cao H et al. | Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. | 2013 | Ann. Thorac. Surg. | pmid:23870696 |
| Walsh MC et al. | Osteoimmunology: interplay between the immune system and bone metabolism. | 2006 | Annu. Rev. Immunol. | pmid:16551243 |
| Theill LE et al. | RANK-L and RANK: T cells, bone loss, and mammalian evolution. | 2002 | Annu. Rev. Immunol. | pmid:11861618 |
| Pettersen I et al. | Osteoprotegerin is expressed in colon carcinoma cells. | 2005 Nov-Dec | Anticancer Res. | pmid:16309167 |
| Katopodis H et al. | MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. | 2009 | Anticancer Res. | pmid:19846944 |
| Zojer N et al. | Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients. | 2005 Sep-Oct | Anticancer Res. | pmid:16101188 |
| Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
| Brown TT et al. | Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. | 2011 | Antivir. Ther. (Lond.) | pmid:22024522 |
| Belibasakis GN et al. | Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. | 2008 | APMIS | pmid:18754324 |
| Krajewski AC et al. | Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. | 2009 | APMIS | pmid:19775343 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Esteghamati A et al. | Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. | 2014 | Arch Iran Med | pmid:25204474 |
| Lee JS et al. | Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. | 2009 | Arch Orthop Trauma Surg | pmid:18427820 |
| Del Fattore A et al. | Osteoclast receptors and signaling. | 2008 | Arch. Biochem. Biophys. | pmid:18237538 |
| Merewether LA et al. | Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. | 2000 | Arch. Biochem. Biophys. | pmid:10683254 |
| Boyce BF and Xing L | Functions of RANKL/RANK/OPG in bone modeling and remodeling. | 2008 | Arch. Biochem. Biophys. | pmid:18395508 |
| Helfrich MH and Hocking LJ | Genetics and aetiology of Pagetic disorders of bone. | 2008 | Arch. Biochem. Biophys. | pmid:18359282 |
| Kuroyanagi G et al. | Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. | 2014 | Arch. Biochem. Biophys. | pmid:24333336 |
| Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Kraj M et al. | Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients. | 2005 Sep-Oct | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:16314829 |
| Åšwierkot J et al. | Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. | 2015 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:25837853 |
| Zdzisińska B et al. | Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells. | 2010 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:20157786 |
| Ugur-Altun B and Altun A | Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women. | 2007 | Arch. Med. Res. | pmid:17923273 |
| Kerr NM et al. | Ocular manifestations of juvenile Paget disease. | 2010 | Arch. Ophthalmol. | pmid:20547946 |
| Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
| Zhang D et al. | The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. | 2004 | Arch. Oral Biol. | pmid:14693199 |
| Nonaka CF et al. | Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. | 2012 | Arch. Oral Biol. | pmid:21871606 |
| Dalla-Bona DA et al. | Cementoblast response to low- and high-intensity ultrasound. | 2008 | Arch. Oral Biol. | pmid:18163974 |
| Wen Y et al. | Application of eGFP to label human periodontal ligament stem cells in periodontal tissue engineering. | 2012 | Arch. Oral Biol. | pmid:22410147 |
| Mayahara K et al. | Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). | 2012 | Arch. Oral Biol. | pmid:22884709 |
| Liao C and Hua Y | Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. | 2013 | Arch. Oral Biol. | pmid:24200305 |
| Luvizuto ER et al. | Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene. | 2010 | Arch. Oral Biol. | pmid:19948337 |
| Wattanaroonwong N et al. | Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. | 2011 | Arch. Oral Biol. | pmid:21035111 |
| Jacobs C et al. | Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. | 2013 | Arch. Oral Biol. | pmid:23422327 |
| Bastos MF et al. | Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: a study in peripubertal rats. | 2014 | Arch. Oral Biol. | pmid:24183604 |
| Nishigaki M et al. | β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:23452546 |
| de Moraes M et al. | Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. | 2011 | Arch. Oral Biol. | pmid:21683340 |
| Sheng ZF et al. | OPG knockout mouse teeth display reduced alveolar bone mass and hypermineralization in enamel and dentin. | 2010 | Arch. Oral Biol. | pmid:20233613 |
| Tazoe M et al. | Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells. | 2003 | Arch. Oral Biol. | pmid:12828991 |
| Luvizuto ER et al. | Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. | 2011 | Arch. Oral Biol. | pmid:21536255 |
| de Souza JA et al. | Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. | 2011 | Arch. Oral Biol. | pmid:21511249 |
| Kim SJ et al. | Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. | 2013 | Arch. Oral Biol. | pmid:23219295 |
| Tang X and Meng H | Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. | 2009 | Arch. Oral Biol. | pmid:19464673 |
| Katono T et al. | Sodium butyrate stimulates mineralized nodule formation and osteoprotegerin expression by human osteoblasts. | 2008 | Arch. Oral Biol. | pmid:18406397 |
| Inubushi T et al. | Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis. | 2014 | Arch. Oral Biol. | pmid:24370195 |
| Wise GE et al. | Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption. | 2002 | Arch. Oral Biol. | pmid:11839361 |
| Kadkhodazadeh M et al. | Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. | 2013 | Arch. Oral Biol. | pmid:23177932 |
| Lee MH et al. | The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:22717323 |
| Heinrich J et al. | CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. | 2005 | Arch. Oral Biol. | pmid:16137499 |
| Neves JS et al. | Immunolocalization of CSF-1, RANKL and OPG in the enamel-related periodontium of the rat incisor and their implications for alveolar bone remodeling. | 2009 | Arch. Oral Biol. | pmid:19419711 |
| Ramirez-Yanez GO and Symons AL | Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: an in vitro study. | 2012 | Arch. Oral Biol. | pmid:22480456 |